Latest Regulatory News

Page 591 of 627
Little Green Pharma reports a robust 75% revenue increase to $9.5 million for December quarter, driven by strong European market growth and strategic product launches.
Ada Torres
Ada Torres
31 Jan 2025
Immutep Limited has initiated its pivotal Phase III trial for eftilagimod alfa in first-line non-small cell lung cancer, supported by compelling survival outcomes from ongoing studies and a robust cash position expected to fund operations through 2026.
Ada Torres
Ada Torres
31 Jan 2025
Brookside Energy Ltd delivered a standout quarter in Q4 2024, posting record production growth and a 667% jump in operating cash flow, while completing a major development project ahead of schedule and under budget.
Maxwell Dee
Maxwell Dee
31 Jan 2025
PainChek Ltd reports robust growth with 100,000 contracted licences globally and positive FDA clearance progress, alongside a promising launch of its Infant App targeting a vast new market.
Ada Torres
Ada Torres
31 Jan 2025
Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.
Victor Sage
Victor Sage
31 Jan 2025
Donaco International posted modest revenue and EBITDA gains in Q2 FY2025, alongside a stronger cash position, while navigating regulatory uncertainties in Southeast Asia.
Victor Sage
Victor Sage
31 Jan 2025
Tigers Realm Coal is finalising the sale of its Russian subsidiaries for US$49 million, pending crucial Presidential approval, while navigating recent leadership shifts.
Maxwell Dee
Maxwell Dee
31 Jan 2025
St Barbara has secured A$100 million to fast-track its Simberi Sulphides project, aiming to bring forward production by up to five months, even as Q2 gold output fell short of expectations due to operational challenges.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Meeka Metals reports steady progress on its Murchison Gold Project, with key infrastructure and processing plant expansions on track for first gold production by mid-2025.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Omni Bridgeway Limited reports strong investment proceeds and new commitments in the first half of FY25, alongside significant cost savings and the imminent financial close of Fund 9 with Ares Management.
Claire Turing
Claire Turing
31 Jan 2025
Almonty Industries has locked in final commitments for an AUD 18.45 million equity placement from existing shareholders, aiming to strengthen its financial position and cover offer costs. The placement includes warrants and options, with closing pending regulatory approval.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Paradigm Biopharmaceuticals has appointed Advanced Clinical as the Clinical Research Organisation for its critical Phase 3 trial targeting knee osteoarthritis pain, setting the stage for patient recruitment and dosing in Q2 2025.
Ada Torres
Ada Torres
31 Jan 2025